Search results for "Estrogen"

showing 10 items of 530 documents

CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells.

2021

ABSTRACTTherapeutic targeting of the estrogen receptor (ER) is a clinically validated approach for estrogen receptor positive breast cancer (ER+ BC), but sustained response is limited by acquired resistance. Targeting the transcriptional coactivators required for estrogen receptor activity represents an alternative approach that is not subject to the same limitations as targeting estrogen receptor itself. In this report we demonstrate that the acetyltransferase activity of coactivator paralogs CREBBP/EP300 represents a promising therapeutic target in ER+ BC. Using the potent and selective inhibitor CPI-1612, we show that CREBBP/EP300 acetyltransferase inhibition potently suppresses in vitro…

Hepatocyte Nuclear Factor 3-alphaMultidisciplinaryReceptors EstrogenAcetyltransferasesCell Line TumorMCF-7 CellsHumansBreast NeoplasmsFemaleCREB-Binding ProteinE1A-Associated p300 ProteinCell ProliferationPloS one
researchProduct

Association Between Exercise and Pubertal BMD Is Modulated by Estrogen Receptor α Genotype

2003

Genetic and environmental factors contribute to bone mass, but the ways they interact remain poorly understood. This study of 245 pre- and early pubertal girls found that the PvuII polymorphism in the ER- gene modulates the effect of exercise on BMD at loaded bone sites. Introduction: Impaired achievement of bone mass at puberty is an important risk factor for the development of osteoporosis in later life. Genetic, as well as environmental, factors contribute to bone mass, but the ways they interact with each other remain poorly understood. Materials and Methods: We investigated the interaction between a PvuII polymorphism at the ER- gene and physical activity (PA) on the modulation of bone…

Heterozygotemedicine.medical_specialtyAdolescentGenotypemedicine.drug_classEndocrinology Diabetes and MetabolismOsteoporosisEstrogen receptorSingle-nucleotide polymorphismPhysical exerciseBiologyBone and BonesBody Mass IndexRisk FactorsInternal medicineGenotypemedicineBody SizeHumansOrthopedics and Sports MedicineChildDeoxyribonucleases Type II Site-SpecificExercisePolymorphism GeneticHomozygotePubertyEstrogen Receptor alphaHeterozygote advantagemedicine.diseaseEndocrinologyEstrogenBody CompositionFemaleBody mass indexJournal of Bone and Mineral Research
researchProduct

Nonhormonal management of postmenopausal women: Effects of a red clover based isoflavones supplementation on climacteric syndrome and cardiovascular …

2013

The aim of this prospective randomized study was to evaluate a red clover based isoflavones supplementation in the treatment of climacteric syndrome and its effects on cardiovascular risk serum profile. Materials and Methods: The study included 150 healthy postmenopausal women that were randomly assigned to receive phytoestrogens tablets, amounting in a total daily intake of 60.8 mg red clover isoflavones plus 19.2 mg soy isoflavones (n = 75), or placebo (n = 75). The authors evaluated teh following: daily number of hot flushes and Kupperman Index at baseline and after one and three months; serum total, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, triglyceri…

Hot FlashePhytoestrogensMiddle AgedIsoflavonesIsoflavoneRisk AssessmentSettore MED/40 - Ginecologia E OstetriciaCardiovascular DiseasesCardiovascular DiseaseHot FlashesPhytoestrogenHumansFemaleTrifoliumHumanPhytotherapy
researchProduct

Estrogen-Induced Mutations and Its Role in the Development of Tumorigenesis

2006

Using RAPD-PCR fingerprinting, the detection of mutations induced by estrogen (E) exposure was studied in nonmalignant- and malignant cells. Cells exposed to 17α-and 17β-estradiol, diethylstilbestrol, bisphenol A, and α-zearalanol induced mutations in different regions of the genome. They consisted of insertion/deletion as a result of point or length mutations and quantitative changes as a result of hypoploidy or polyploidy. We also detected several mutated loci in tumor-free tissues, adjacent to tumors, and DES-induced tumors. The data suggest that these mutations occurred in early stages of stilbene E-induced renal carcinogenesis, and that they may be induced as a result of stilbene E tre…

HypoploidyEstrogenmedicine.drug_classCancer researchDiethylstilbestrolmedicineMalignant cellsBiologyCarcinogenesismedicine.disease_causeRenal carcinogenesisGenomemedicine.drug
researchProduct

Micropollutants removal in an anaerobic membrane bioreactor and in an aerobic conventional treatment plant

2012

The paper expresses an attempt to tackle the problem due to the presence of micropollutants in wastewater which may be able to disrupt the endocrine system of some organisms. These kinds of compounds are ubiquitously present in municipal wastewater treatment plant (WWTP) effluents. The aim of this paper is to compare the fate of the alkylphenols-APs (4-(tert-octyl)) phenol, t-nonylphenol and 4-p-nonylphenol and the hormones (estrone, 17ß-estradiol and 17¿-ethinylestradiol) in a submerged anaerobic membrane bioreactor (SAMBR) pilot plant and in a conventional activated sludge wastewater treatment plant (CTP). The obtained results are also compared with the results obtained in a previous stud…

INGENIERIA HIDRAULICAUnclassified drugEffluentsExtractionEstrogenic hormonesOxic conditionsMembrane bioreactorDegradationBioreactorsEndocrinologyChemical structureLimit of Detection(4 (tert octyl)) phenolWater PollutantsAnaerobiosisWater Science and TechnologyPilot plantsWaste water managementEstradiolChemistryMembranePhenol derivativeWater samplingPulp and paper industryWaste treatmentEndocrine disruptorWastewaterPollutant removalMembrane bioreactorSewage treatmentActivated sludge plantsAnaerobic exerciseAnaerobic membrane bioreactorActivated sludge plantChromatography GasEnvironmental EngineeringWaste water treatment plantHydraulic retention timeEstroneBioreactorMass fragmentographyPollutantSewage pumping plantsArticlePhenolsEthinylestradiolBioreactorWater treatment plantsEffluentSolid Phase MicroextractionTECNOLOGIA DEL MEDIO AMBIENTE3 nonylphenolChromatography4 nonylphenolAlkylphenol polyoxyethyl etherMembranes ArtificialAlkylphenolsHormoneHormonesActivated sludgeActivated sludgeAnoxic conditionsWater Science and Technology
researchProduct

Estrogens control inflammation in experimental colitis.

2014

There is now a wealth of experimental evidence indicating that the deficit in endogenous estrogen facilitates the onset of inflammation that can be antagonized by estrogen replacement therapy. This work investigated the role of estrogen in the control of intestinal inflammation in a panel of colitis models, focusing on the morphological changes, the activity of mast cells, the expression of cytokines (IL-1beta, IL-6, and TNF-alpha), fibronectin and reactive oxygen species. Two hundred adult male rats were divided into 4 groups: colitis was induced in Group I and Group II but only the latter was treated with estrogen; Group III received estrogen only, and Group IV saline. Colitis was induced…

InflammationMaleRats Sprague-DawleyDisease Models AnimalColonestrogens colitis inflammation.AnimalsCytokinesEstrogensMast CellsColitisFibronectinsRats
researchProduct

Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli.

2006

Abstract Purpose: Recent in vitro studies suggested that the autocrine leptin loop might contribute to breast cancer development by enhancing cell growth and survival. To evaluate whether the leptin system could become a target in breast cancer therapy, we examined the expression of leptin and its receptor (ObR) in primary and metastatic breast cancer and noncancer mammary epithelium. We also studied whether the expression of leptin/ObR in breast cancer can be induced by obesity-related stimuli, such as elevated levels of insulin, insulin-like growth factor-I (IGF-I), estradiol, or hypoxic conditions. Experimental Design: The expression of leptin and ObR was examined by immunohistochemistry…

LeptinCancer ResearchER-BETAmedicine.medical_treatmentHYPOXIA-INDUCIBLE FACTOR-1NeoplasmsTumor Cells CulturedBreastInsulin-Like Growth Factor Iskin and connective tissue diseasesReceptorAged 80 and overEstradiolIGF-I RECEPTORCELL-LINEReverse Transcriptase Polymerase Chain ReactionLeptindigestive oral and skin physiologyCarcinoma Ductal BreastMiddle AgedMetastatic breast cancerINSULINCell HypoxiaESTROGENOncologyDisease ProgressionIGF-I RECEPTOR; HYPOXIA-INDUCIBLE FACTOR-1; OB GENE; GROWTH-FACTOR; CELL-LINE; ER-BETA; ESTROGEN; ALPHA; INSULIN; MCF-7Receptors LeptinFemaleOB GENEhormones hormone substitutes and hormone antagonistsAdultmedicine.medical_specialtyGROWTH-FACTORBreast NeoplasmsReceptors Cell SurfaceBreast cancerInternal medicinemedicineBiomarkers TumorHumansObesityAutocrine signallingAgedLeptin receptorbusiness.industryInsulinmedicine.diseaseALPHAEndocrinologyTumor progressionCase-Control StudiesMCF-7business
researchProduct

Differential expression of estrogen receptors (ER?/ER?) in testis of mature and immature pigs

2004

High affinity estrogen receptors (ERs) mediate estrogen action in male reproductive tissues. The objective of the present study was the immunolocalization of estrogen receptor alpha and estrogen receptor beta in immature and mature testes of pig, a species in which the role of estrogens on gonadal function is scarcely known. Testes from 3 and 18 month-old pigs were investigated. Immunohistochemistry was performed on paraffin embedded-tissues using both mouse anti-human monoclonal IgG ERalpha and IgG ERbeta 1 isoform. Western blot analysis demonstrated antibody specificity. ERalpha staining was not observed in immature testes, but it was detected in spermatogonia, spermatocytes and in the mo…

Leydig CellMaleendocrine systemmedicine.medical_specialtySwinemedicine.drug_classSomatic cellBlotting WesternImmunoenzyme TechniqueEstrogen receptorBiologyHeLa CellImmunoenzyme TechniquesWestern blotSpermatocytesInternal medicineTestismedicineAnimalsHumansEstrogen receptorEstrogen Receptor betaEstrogen receptor betaPig developmentmedicine.diagnostic_testAnimalurogenital systemEstrogen Receptor alphaLeydig CellsAntibodies MonoclonalEstrogenAgricultural and Biological Sciences (miscellaneous)SpermatogoniaSpermatocyteBlotEndocrinologyTestiEstrogenImmunohistochemistryAnatomyEstrogen receptor alphahormones hormone substitutes and hormone antagonistsHeLa CellsHumanThe Anatomical Record
researchProduct

Expressional control of the ‘constitutive’ isoforms of nitric oxide synthase (NOS I and NOS III)

1998

Nitric oxide synthase (NOS) exists in three established isoforms. NOS I (NOS1, ncNOS) was originally discovered in neurons. This enzyme and splice variants thereof have since been found in many other cells and tissues. NOS II (NOS2, iNOS) was first identified in murine macrophages, but can also be induced in many other cell types. NOS III (NOS3, ecNOS) is expressed mainly in endothelial cells. Whereas NOS II is a transcriptionally regulated enzyme, NOS I and NOS III are considered constitutively expressed proteins. However, evidence generated in recent years indicates that these two isoforms are also subject to expressional regulation. In view of the important biological functions of these …

LipopolysaccharidesGene isoformNitric Oxide Synthase Type IIITranscription GeneticNOS1Nitric Oxide Synthase Type IBiochemistryTranscription (biology)GeneticsTranscriptional regulationAnimalsHumansRNA MessengerGrowth SubstancesMolecular BiologyTranscription factorRegulation of gene expressionPolymorphism GeneticbiologyChemistryChromosome MappingLysophosphatidylcholinesNitric Oxide Synthase Type IIIEstrogensExonsCell biologyIsoenzymesLipoproteins LDLOxygenNitric oxide synthaseGene Expression Regulationbiology.proteinCytokinesNitric Oxide SynthaseGene DeletionBiotechnologyThe FASEB Journal
researchProduct

Induction of 2-hydroxycatecholestrogens O-methylation: A missing puzzle piece in diagnostics and treatment of lung cancer

2022

Lung cancer is one of the most common cancers worldwide, causing nearly one million deaths each year. Herein, we present the effect of 2-methoxyestradiol (2-ME), the endogenous metabolite of 17β-estradiol (E2), on non-small cell lung cancer (NSCLC) cells. We observed that 2-ME reduced the viability of lung adenocarcinoma in two-dimensional (2D) and three-dimensional (3D) spheroidal A549 cell culture models. Molecular modeling was carried out aiming to visualize amino acid residues within binding pockets of the acyl-protein thioesterases, namely 1 (APT1) and 2 (APT2), and thus to identify which ones were more likely involved in the interaction with 2-ME. Our findings suggest that 2-ME acts a…

Lung adenocarcinomaEstrogen metabolitesNon-small cell lung cancerelectrophilic potentialOrganic ChemistryClinical BiochemistryMolecular modelingBiomarkerLung cancerBlood serumBiochemistry2-Methoxyestradiol
researchProduct